Royal Cargo Inc., a specialized end-to-end logistics solutions provider, has announced that its South Hub has officially renewed its Good Distribution Practice (GDP) certification for Pharmaceutical Warehousing and Distribution.
This recertification serves as a testament to the company’s unwavering commitment to maintaining the highest international standards in the handling of life-saving medical products.
The GDP renewal is more than just a regulatory milestone; it is a critical component of Royal Cargo’s integrated healthcare supply chain strategy. By adhering to these stringent global protocols, the South Hub ensures that the integrity and quality of pharmaceutical products are maintained throughout every stage of the storage and distribution process.
This achievement is complemented by Royal Cargo’s existing FDA licenses as a Drug and Medical Device Manufacturer, positioning the company as a premier partner for global pharmaceutical firms and local healthcare providers.
“The renewal of our GDP certification reflects the steady development of Royal Cargo’s pharma and healthcare capabilities,” said a spokesperson for Royal Cargo. “By combining specialized infrastructure with rigorous quality management, we are providing the Philippine market with the reliability required for sensitive medical shipments.”
Key highlights of the South Hub’s capabilities include:
-
Temperature-Controlled Excellence: Advanced cold chain solutions designed for vaccines, biologics, and specialized medicines.
-
Regulatory Compliance: Full alignment with Department of Health (DOH) and Food and Drug Administration (FDA) requirements.
-
End-to-End Visibility: Integrated tracking systems that ensure product safety from the warehouse floor to the final destination.
